Skip to Main Content

Author Details

Mathieu Tremblay
Universite de Montreal, Institute for Research in Immunology and Cancer
2003
21
16
Sami Nourreddine (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35589701Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.Nat Commun2022
35401501Monoallelic <i>Heb/Tcf12</i> Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.Front Immunol2022
32894216Regulation of stem/progenitor cell maintenance by BMP5 in prostate homeostasis and cancer initiation.Elife2020
30348673GATA transcription factors in development and disease.Development2018
27964993Laminin is instructive and calmodulin dependent kinase II is non-permissive for the formation of complex aggregates of acetylcholine receptors on myotubes in culture.Matrix Biol2017
28285879Lineage Specification from Prostate Progenitor Cells Requires Gata3-Dependent Mitotic Spindle Orientation.Stem Cell Reports2017
28705896Bmp signaling maintains a mesoderm progenitor cell state in the mouse tailbud.Development2017
26859289A Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney Defects.PLoS Genet2016
27797342High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.J Clin Invest2016
25522233SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.PLoS Genet2014
23428429Gata3 antagonizes cancer progression in Pten-deficient prostates.Hum Mol Genet2013
23898169RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells.Proc Natl Acad Sci U S A2013
23836559Genetic interaction between Kit and Scl.Blood2013
23920117A core transcriptional network composed of Pax2/8, Gata3 and Lim1 regulates key players of pro/mesonephros morphogenesis.Dev Biol2013
20516195Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.Genes Dev2010
19114552Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer.Mol Cell Biol2009
17283046c-Jun homodimers can function as a context-specific coactivator.Mol Cell Biol2007
17878155Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction.J Biol Chem2007
16531403An extracellular pathway for dystroglycan function in acetylcholine receptor aggregation and laminin deposition in skeletal myotubes.J Biol Chem2006
15728588Evidence that dystroglycan is associated with dynamin and regulates endocytosis.J Biol Chem2005
12566462Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL.J Biol Chem2003
  • 1 - 21 of 21

Recommended Authors

McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Boston Children's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 1
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Karolinska Institutet
Career Start Year 2003
Number of shared co-authors 1
Masaryk University
Career Start Year 2001
Number of shared co-authors 0
Whitehead Institute for Biomedical Research
Career Start Year 2000
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 0
Stanford University
Career Start Year 1997
Number of shared co-authors 0
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1995
Number of shared co-authors 1
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1993
Number of shared co-authors 0
Maastricht University
Career Start Year 1992
Number of shared co-authors 0
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 1990
Number of shared co-authors 1
University of Florida College of Veterinary Medicine
Career Start Year 1990
Number of shared co-authors 0
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 1
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 0
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 0
Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University
Career Start Year 1987
Number of shared co-authors 0
Center for Molecular Medicine, University of Georgia
Career Start Year 1986
Number of shared co-authors 0
RIKEN Research Center for Allergy and Immunology
Career Start Year 1986
Number of shared co-authors 1
Department of Genetics and Institute for Diabetes, University of Pennsylvania
Career Start Year 1986
Number of shared co-authors 1
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Career Start Year 1985
Number of shared co-authors 1
Princess Maxima Center for Pediatric Oncology
Career Start Year 1985
Number of shared co-authors 0
Institut de recherches cliniques de Montreal
Career Start Year 1985
Number of shared co-authors 1
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 2
University of California
Career Start Year 1982
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 0
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1967
Number of shared co-authors 3

Collaborators

Department of Biomedical Science and Center for Bio-Nanomaterials, Daegu University
Co-authored papers 11
Universite de Montreal, Institute for Research in Immunology and Cancer
Co-authored papers 6
Universite de Toulouse, Inserm, Universite Toulouse III-Paul Sabatier
Co-authored papers 4
University of Campinas (UNICAMP)
Co-authored papers 4
Universite de Montreal
Co-authored papers 4
Universite de Montreal
Co-authored papers 3
Co-authored papers 3
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers 2
Institute for Research in Immunology and Cancer
Co-authored papers 2
University of Montreal
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1
Walter and Eliza Hall Institute of Medical Research
Co-authored papers 1
University of Montreal Health Center
Co-authored papers 1
Institute for Research in Immunology and Cancer (IRIC)
Co-authored papers 1
Leslie Dan Faculty of Pharmacy and Department of Biochemistry, University of Toronto
Co-authored papers 1
McGill University
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Universite de Montreal
Co-authored papers 1
Yong Loo Lin School of Medicine, National University of Singapore
Co-authored papers 1
McGill University
Co-authored papers 1
Centre hospitalier universitaire de l'Universite de Montreal (CHUM)
Co-authored papers 1
IRIC - University of Montreal
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Harvard Stem Cell Institute, Harvard Medical School
Co-authored papers 1
The Leucegene Project at Institute for Research in Immunology and Cancer.
Co-authored papers 1
Institute for Research in Immunology and Cancer, University of Montreal
Co-authored papers 1
Institute for Research in Immunology and Cancer, Universite de Montreal
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1